Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovar...
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors
About this item
Full title
Author / Creator
Musacchio, Lucia , Boccia, Serena , Marchetti, Claudia , Minucci, Angelo , Camarda, Floriana , Cassani, Chiara , Ventriglia, Jole , Salutari, Vanda , Ghizzoni, Viola , Giudice, Elena , Perri, Maria Teresa , Carbone, Maria Vittoria , Ricci, Caterina , Pignata, Sandro , Fagotti, Anna , Scambia, Giovanni and Lorusso, Domenica
Publisher
United States: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
ObjectiveCorrelation between BRCA1/2 (BRCA) pathogenic variants and the response to poly (ADP-ribose) polymerase inhibitors (PARPi) has been recognized in patients with ovarian cancer. Moreover, data on the clinical implications of variants of unknown significance are lacking. The aim of this study was to evaluate differences in survival outcomes i...
Alternative Titles
Full title
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2775624413
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2775624413
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2022-003903
